Raymond James Trust’s Healthcare Services Group HCSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,900
Closed -$216K 1144
2022
Q3
$216K Hold
17,900
0.01% 945
2022
Q2
$312K Hold
17,900
0.01% 791
2022
Q1
$332K Hold
17,900
0.01% 825
2021
Q4
$318K Sell
17,900
-2,200
-11% -$42.8K 0.01% 874
2021
Q3
$502K Hold
20,100
0.02% 615
2021
Q2
$635K Hold
20,100
0.02% 526
2021
Q1
$563K Buy
20,100
+2,100
+12% +$63.4K 0.02% 549
2020
Q4
$506K Sell
18,000
-3,000
-14% -$72.6K 0.02% 535
2020
Q3
$452K Sell
21,000
-1,650
-7% -$38.5K 0.02% 521
2020
Q2
$554K Buy
22,650
+2,507
+12% +$59.3K 0.03% 439
2020
Q1
$482K Sell
20,143
-535
-3% -$13.8K 0.03% 406
2019
Q4
$503K Buy
20,678
+283
+1% +$7.01K 0.02% 464
2019
Q3
$495K Buy
20,395
+5,395
+36% +$136K 0.03% 458
2019
Q2
$455K Buy
15,000
+2,407
+19% +$79.5K 0.03% 466
2019
Q1
$415K Sell
12,593
-180
-1% -$6.89K 0.02% 483
2018
Q4
$513K Sell
12,773
-111
-0.9% -$4.69K 0.03% 393
2018
Q3
$523K Buy
12,884
+8,190
+174% +$340K 0.03% 422
2018
Q2
$203K Buy
+4,694
New +$186K 0.01% 777

Other funds holding HCSG

Raymond James Trust's HCSG Position: Q4 2022 in Review

Raymond James Trust sold out of Healthcare Services Group (HCSG) in Q4 2022, closing a stake of 17,900 shares — an estimated $216K sold.

Raymond James Trust first reported a position in HCSG in Q2 2018 and held it in 18 quarters. The position peaked at $635K in Q2 2021. 201 funds tracked by Wall St. Rank hold HCSG as of Q4 2022.

  • Raymond James Trust reported no remaining Healthcare Services Group position as of Q4 2022 after selling out during the quarter.
  • Raymond James Trust sold 17,900 Healthcare Services Group shares in Q4 2022, an estimated $216K.
  • Raymond James Trust first reported a position in Healthcare Services Group in Q2 2018 and held it in 18 quarters.
  • Raymond James Trust's Healthcare Services Group position peaked at $635K in Q2 2021.
  • 201 funds tracked by Wall St. Rank held Healthcare Services Group as of Q4 2022.

Based on Raymond James Trust's 13F filing for Q4 2022, filed 2 Feb 2023.